CN1682986A - 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 - Google Patents
治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN1682986A CN1682986A CN 200510011402 CN200510011402A CN1682986A CN 1682986 A CN1682986 A CN 1682986A CN 200510011402 CN200510011402 CN 200510011402 CN 200510011402 A CN200510011402 A CN 200510011402A CN 1682986 A CN1682986 A CN 1682986A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- rhizoma
- medicine composition
- grams
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 201000010099 disease Diseases 0.000 title description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 6
- 210000002229 urogenital system Anatomy 0.000 title description 3
- 238000000034 method Methods 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 55
- 238000002360 preparation method Methods 0.000 claims abstract description 16
- 206010061218 Inflammation Diseases 0.000 claims abstract description 4
- 230000004054 inflammatory process Effects 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 55
- 241000903946 Clematidis Species 0.000 claims description 26
- 241000628997 Flos Species 0.000 claims description 26
- 239000008187 granular material Substances 0.000 claims description 19
- 238000002156 mixing Methods 0.000 claims description 15
- 208000019206 urinary tract infection Diseases 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 230000001154 acute effect Effects 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000003826 tablet Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000007938 effervescent tablet Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 5
- 230000035619 diuresis Effects 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 3
- 230000036407 pain Effects 0.000 abstract description 3
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 241000282817 Bovidae Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 230000004083 survival effect Effects 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 9
- 210000002700 urine Anatomy 0.000 description 8
- 230000001684 chronic effect Effects 0.000 description 7
- 206010018612 Gonorrhoea Diseases 0.000 description 6
- 208000019802 Sexually transmitted disease Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 229940098166 bactrim Drugs 0.000 description 6
- 208000001786 gonorrhea Diseases 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000009533 lab test Methods 0.000 description 6
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 6
- 241000588767 Proteus vulgaris Species 0.000 description 5
- 230000006837 decompression Effects 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 238000004321 preservation Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 201000010153 skin papilloma Diseases 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 201000004538 Bacteriuria Diseases 0.000 description 4
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 229940007042 proteus vulgaris Drugs 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 206010059313 Anogenital warts Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 3
- 241000649484 Callosa Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000588653 Neisseria Species 0.000 description 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 3
- 206010037596 Pyelonephritis Diseases 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 229960001138 acetylsalicylic acid Drugs 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 229960002003 hydrochlorothiazide Drugs 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 208000001387 Causalgia Diseases 0.000 description 2
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 102000009338 Gastric Mucins Human genes 0.000 description 2
- 108010009066 Gastric Mucins Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- PQMWYJDJHJQZDE-UHFFFAOYSA-M Methantheline bromide Chemical compound [Br-].C1=CC=C2C(C(=O)OCC[N+](C)(CC)CC)C3=CC=CC=C3OC2=C1 PQMWYJDJHJQZDE-UHFFFAOYSA-M 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 2
- 241000934136 Verruca Species 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 201000000695 acute gonococcal prostatitis Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 201000004196 common wart Diseases 0.000 description 2
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000027832 gonococcal prostatitis Diseases 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 201000004303 plantar wart Diseases 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 201000007094 prostatitis Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003708 urethra Anatomy 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000001688 Herpes Genitalis Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 201000004946 genital herpes Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 230000010503 organ complication Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 206010038464 renal hypertension Diseases 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g/kg) | 动物数 | 存活数 | 存活率(%) |
空白 | 24 | 2 | 8.33 | |
低剂量组 | 1.0 | 24 | 4 | 16.66 |
中剂量组 | 2.0 | 28 | 10 | 35.71* |
高剂量组 | 4.0 | 28 | 14 | 50.00** |
复方新诺明 | 0.24 | 24 | 22 | 91.66*** |
组别 | 剂量(g/kg) | 动物数 | 存活数 | 存活率(%) |
空白 | 20 | 2 | 10.00 |
低剂量组 | 1.0 | 21 | 4 | 19.04 |
中剂量组 | 2.0 | 20 | 8 | 40.00* |
高剂量组 | 4.0 | 20 | 10 | 50.00** |
复方新诺明 | 0.24 | 20 | 14 | 70.00*** |
组别 | 剂量(g/kg) | 动物数 | 存活数 | 存活率(%) |
空白 | 30 | 3 | 10.00 | |
低剂量组 | 1.0 | 30 | 1 | 3.3 |
中剂量组 | 2.0 | 30 | 5 | 16.7 |
高剂量组 | 4.0 | 30 | 8 | 26.7 |
复方新诺明 | 0.2 | 30 | 29 | 96.7*** |
组别 | 剂量(g/kg) | 动物数 | 存活数 | 存活率(%) |
空白 | 30 | 1 | 3.3 | |
低剂量组 | 1.0 | 30 | 1 | 3.3 |
中剂量组 | 2.0 | 30 | 3 | 10.0 |
高剂量组 | 4.0 | 30 | 5 | 16.7 |
复方新诺明 | 0.2 | 30 | 20 | 66.7*** |
肿胀率(%)(X/±SD) | ||||||||
分组 | 剂量(g/kg) | 动物数 | 正常 | 30分 | 1小时 | 2小时 | 4小时 | 6小时 |
空白 | 10 | 1.49±0.11 | 39.60±9.09 | 36.49±10.22 | 36.74±11.70 | 2991±10.41 | 23.79±11.15 | |
低剂量组 | 0.45 | 10 | 1.44±0.06 | 36.07±7.64 | 31.53±8.14 | 28.15*±9.26 | 23.56±7.75 | 16.41±6.27 |
中剂量组 | 0.90 | 10 | 1.49±0.15 | 29.65***±8.10 | 27.54*±7.32 | 22.63±6.99 | 15.83***±3.86 | 0.64***±4.07 |
高剂量组 | 1.80 | 10 | 1.45±0.13 | 26.52**±11.00 | 23.69**±10.14 | 20.72***±11.34 | 15.39**±10.75 | 9.52**±6.98 |
阿斯匹林 | 0.30 | 10 | 1.43±0.10 | 27.54***±10.86 | 26.39***±11.90 | 20.91***±13.87 | 16.22***±11.50 | 8.94***±8.74 |
分组 | 剂量(g/kg) | 动物数 | 尿量(ml) |
空白 | 11 | 3.72±1.02 | |
低剂量组 | 0.45 | 11 | 5.60±1.35** |
中剂量组 | 0.90 | 11 | 7.24±2.21*** |
高剂量组 | 1.80 | 11 | 9.97±2.13*** |
氢氯噻嗪 | 0.01 | 11 | 11.31±0.88*** |
组别 | 例数 | 近期治愈N(%) | 显效N(%) | 有效N(%) | 无效N(%) | 愈显率% | 总有效率% |
治疗组1 | 163 | 83(50.92) | 34(20.86) | 33(20.25) | 13(7.98) | 71.78 | 92.02 |
对照组 | 100 | 27(27) | 23(23.00) | 25(25.00) | 25(25.00) | 50.00 | 75.00 |
治疗组2 | 151 | 79(52.32) | 34(22.52) | 26(17.22) | 12(7.95) | 74.83 | 92.05 |
类别 | 组别 | 治疗前(N) | 治疗后 | |
菌尿转阴(n) | 菌尿持续阳性(n) | |||
2周 | 治疗组1 | 63 | 49(77.77) | 14(22.23) |
对照组 | 48 | 21(43.75) | 27(56.25) | |
治疗组2 | 70 | 45(64.29) | 25(35.71) | |
6周 | 治疗组1 | 63 | 50(79.37) | 13(20.63) |
对照组 | 48 | 32(66.67) | 16(33.33) | |
治疗组2 | 70 | 60(85.71) | 10(14.29) |
症状 | 治疗组1 N=163 | |||||||
疗前 | 疗后 | |||||||
+++ | ++ | + | - | +++ | ++ | + | - | |
尿频 | 28 | 94 | 39 | 2 | 0 | 5 | 58 | 100 |
尿急 | 29 | 75 | 53 | 6 | 0 | 6 | 42 | 115 |
尿道灼痛或淋漓涩痛 | 27 | 47 | 77 | 12 | 1 | 5 | 27 | 130 |
尿黄赤 | 29 | 91 | 30 | 13 | 0 | 12 | 49 | 102 |
小腹胀痛 | 17 | 53 | 68 | 25 | 0 | 5 | 26 | 132 |
腰痛 | 13 | 48 | 27 | 1 | 3 | 27 | 132 | 75 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100114022A CN100344319C (zh) | 2005-03-09 | 2005-03-09 | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100114022A CN100344319C (zh) | 2005-03-09 | 2005-03-09 | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1682986A true CN1682986A (zh) | 2005-10-19 |
CN100344319C CN100344319C (zh) | 2007-10-24 |
Family
ID=35262605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100114022A Active CN100344319C (zh) | 2005-03-09 | 2005-03-09 | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100344319C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361914B (zh) * | 2008-10-08 | 2011-08-03 | 王恒 | 一种治疗口腔癌的中药配方 |
CN102526642A (zh) * | 2012-03-20 | 2012-07-04 | 南宁市品迪生物工程有限公司 | 前列腺炎综合疗法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1048173C (zh) * | 1994-08-11 | 2000-01-12 | 王志明 | 一种治疗性病的中药制剂及其制备方法 |
-
2005
- 2005-03-09 CN CNB2005100114022A patent/CN100344319C/zh active Active
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101361914B (zh) * | 2008-10-08 | 2011-08-03 | 王恒 | 一种治疗口腔癌的中药配方 |
CN102526642A (zh) * | 2012-03-20 | 2012-07-04 | 南宁市品迪生物工程有限公司 | 前列腺炎综合疗法 |
CN102526642B (zh) * | 2012-03-20 | 2013-12-11 | 南宁市品迪生物工程有限公司 | 前列腺炎综合疗法 |
Also Published As
Publication number | Publication date |
---|---|
CN100344319C (zh) | 2007-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1857681A (zh) | 胃病制剂及新的制备方法 | |
CN103006916A (zh) | 一种治疗各种动物腹泻病的纯中药配方及其制备方法 | |
CN1682842A (zh) | 一种消炎解毒的中药组合物及其制备方法和用途 | |
CN104491052B (zh) | 治疗风湿及类风湿性关节炎的中药组合物及其制备方法 | |
CN1221277C (zh) | 一种预防和治疗肺炎、支气管炎、咽炎及上呼吸道感染的药物及其制备方法 | |
CN1806821A (zh) | 一种治疗鼻炎的药物 | |
CN101564458A (zh) | 一种中药组合物在制备治疗支气管炎药物中的应用 | |
CN100344319C (zh) | 治疗泌尿生殖系统疾病的中药组合物及其制备方法和用途 | |
CN1927279A (zh) | 一种用于皮肤病的中药组合物 | |
CN103394002B (zh) | 一种治疗皮肤瘙痒的药物组合物及其制备方法和用途 | |
CN100337645C (zh) | 一种治疗急性咽炎的药物组合物及其制备方法 | |
CN1168488C (zh) | 治疗热淋的中药制剂 | |
CN1879701A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN1990033A (zh) | 一种治疗高血压、血稠、动脉硬化的药物 | |
CN1186067C (zh) | 治疗急性筋伤的药物及其制备方法 | |
CN1278709C (zh) | 一种治疗感冒的药物及其制备方法 | |
CN1219527C (zh) | 治疗痤疮的软膏及其制备方法 | |
CN101637558B (zh) | 一种治疗血小板减少性紫癜的药物 | |
CN1931279A (zh) | 治疗胆道感染的药物及其制备方法 | |
CN1255146C (zh) | 一种治疗上呼吸道感染的药物组合物及其制备方法 | |
CN100339126C (zh) | 一种治疗和预防胆道炎症的中药及其制备工艺 | |
CN1500505A (zh) | 一种治疗小儿病毒性肺炎的药物组合物及其制备方法 | |
CN100333744C (zh) | 一种治疗痤疮的药物 | |
CN1088378C (zh) | 治疗慢性浅表性胃炎的中药口服液及其制备方法 | |
CN1899558A (zh) | 一种治疗胃病的药物组合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Free format text: FORMER OWNER: WANG ZHIMING Effective date: 20121203 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100021 CHAOYANG, BEIJING TO: 274000 HEZE, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121203 Address after: 274000 No. 369 Zhonghua West Road, Heze, Shandong Patentee after: Shandong Buchang Pharmaceuticals Co., Ltd. Address before: 100021, Beijing, Chaoyang District Panjiayuan South 26 floor, 207 Patentee before: Wang Zhiming |